BRCA1/2 germline mutations and response to PARP inhibitor treatment in lung cancer.

被引：6

作者：

Fang, Wenfeng

Cai, Xiuyu

Zhou, Huaqiang

Wang, Yinguang

Zhang, Yaxiong

Hong, Shaodong

Shao, Yang

Zhang, Li

机构：

[1] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China

[2] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[3] Nanjing Geneseeq Technol Inc, Nanjing, Jiangsu, Peoples R China

[4] Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON, Canada

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.e13007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e13007

引用

页数：1